News Chart MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq Other stock markets 01:30:00 19/06/2024 am IST			5-day change	1st Jan Change
39.49 ^USD	-1.69%		-9.05%	-34.61%

10/06	MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from Both FDA and EMA on Path for the Phase 3 Program for the Nanobody Sonelokimab in Psoriatic Arthritis	CI
07/05	MoonLake Immunotherapeutics Q1 Net Loss Widens	MT

958413f68fc7f6607feec3de2cb.2rs9gwj0S55vmyMqfBzIqUqZC7KjEvOFFJcdn0H0JNU.ktBkxU-3Hd8j30wcBmSvmgWubcSOeoXPIKVX8wmdd7Og80TKWYMx-R3wFw~c2290eddc6d2fd912c9ac98af022954d